🇺🇸 FDA
Patent

US 10028974

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

granted A61KA61K31/7088A61K31/713

Quick answer

US patent 10028974 (MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes) held by Julius-Maximilians-Universitat Wurzburg expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Julius-Maximilians-Universitat Wurzburg
Grant date
Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/7088, A61K31/713, A61K45/06, A61P